Pensions

198,953 Shares in Thermo Fisher Scientific Inc. (TMO) Acquired by British Airways Pensions Investment Management Ltd

British Airways Pensions Investment Management Ltd purchased a new stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor purchased 198,953 shares of the medical research company’s stock, valued at approximately $34,691,000. British Airways Pensions Investment Management Ltd owned about 0.05% of Thermo Fisher Scientific at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Proficio Capital Partners LLC grew its stake in Thermo Fisher Scientific by 71.5% in the 1st quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock worth $105,000 after acquiring an additional 253 shares in the last quarter. Chicago Partners Investment Group LLC bought a new position in Thermo Fisher Scientific in the 2nd quarter worth about $108,000. Cribstone Capital Management LLC grew its stake in Thermo Fisher Scientific by 8.7% in the 2nd quarter. Cribstone Capital Management LLC now owns 625 shares of the medical research company’s stock worth $109,000 after acquiring an additional 50 shares in the last quarter. Sharkey Howes & Javer grew its stake in Thermo Fisher Scientific by 1.0% in the 1st quarter. Sharkey Howes & Javer now owns 733 shares of the medical research company’s stock worth $113,000 after acquiring an additional 7 shares in the last quarter. Finally, CWM LLC grew its stake in Thermo Fisher Scientific by 17.0% in the 2nd quarter. CWM LLC now owns 710 shares of the medical research company’s stock worth $124,000 after acquiring an additional 103 shares in the last quarter. Institutional investors own 83.52% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This news story was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this news story can be read at https://www.dispatchtribunal.com/2017/09/17/198953-shares-in-thermo-fisher-scientific-inc-tmo-acquired-by-british-airways-pensions-investment-management-ltd.html.

A number of equities analysts have commented on the stock. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $214.00 target price on the stock in a research note on Thursday. Cowen and Company restated an “outperform” rating and issued a $220.00 target price (up from $200.00) on shares of Thermo Fisher Scientific in a research note on Sunday, September 10th. Morgan Stanley restated an “overweight” rating and issued a $220.00 target price on shares of Thermo Fisher Scientific in a research note on Wednesday, September 6th. Argus restated a “buy” rating on shares of Thermo Fisher Scientific in a research note on Tuesday, August 22nd. They noted that the move was a valuation call. Finally, BidaskClub downgraded shares of Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. One investment analyst has rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $193.56.

Shares of Thermo Fisher Scientific Inc. (NYSE TMO) opened at 190.63 on Friday. The stock has a market cap of $74.37 billion, a PE ratio of 33.21 and a beta of 1.05. The company’s 50-day moving average is $180.21 and its 200-day moving average is $170.53. Thermo Fisher Scientific Inc. has a 52-week low of $139.07 and a 52-week high of $194.30.

Thermo Fisher Scientific (NYSE:TMO) last issued its earnings results on Wednesday, July 26th. The medical research company reported $2.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.27 by $0.03. Thermo Fisher Scientific had a net margin of 12.27% and a return on equity of 11.11%. The business had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.92 billion. During the same quarter in the prior year, the business posted $2.03 EPS. The company’s revenue for the quarter was up 10.2% on a year-over-year basis. Equities analysts anticipate that Thermo Fisher Scientific Inc. will post $9.35 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Friday, September 15th will be given a $0.15 dividend. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $0.60 annualized dividend and a yield of 0.31%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 10.45%.

In other news, Director Jim P. Manzi sold 11,318 shares of the company’s stock in a transaction on Friday, August 18th. The shares were sold at an average price of $172.94, for a total transaction of $1,957,334.92. Following the transaction, the director now directly owns 38,757 shares of the company’s stock, valued at approximately $6,702,635.58. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, VP Seth H. Hoogasian sold 4,140 shares of the company’s stock in a transaction on Monday, August 28th. The stock was sold at an average price of $177.80, for a total transaction of $736,092.00. Following the transaction, the vice president now directly owns 25,518 shares in the company, valued at $4,537,100.40. The disclosure for this sale can be found here. In the last quarter, insiders sold 22,738 shares of company stock valued at $4,021,512. 0.49% of the stock is owned by insiders.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)




Receive News & Ratings for Thermo Fisher Scientific Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Thermo Fisher Scientific Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *

seventeen + 12 =